1. Home
  2. ICLR vs SNEX Comparison

ICLR vs SNEX Comparison

Compare ICLR & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$172.48

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$70.46

Market Cap

8.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICLR
SNEX
Founded
1990
1924
Country
Ireland
United States
Employees
N/A
5400
Industry
Biotechnology: Commercial Physical & Biological Resarch
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.4B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
ICLR
SNEX
Price
$172.48
$70.46
Analyst Decision
Buy
Strong Buy
Analyst Count
13
1
Target Price
$178.62
$81.33
AVG Volume (30 Days)
532.6K
763.8K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
3.49
Revenue
N/A
$132,378,200,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.17
P/E Ratio
$12.91
$19.87
Revenue Growth
N/A
32.53
52 Week Low
$66.57
$63.33
52 Week High
$203.91
$141.99

Technical Indicators

Market Signals
Indicator
ICLR
SNEX
Relative Strength Index (RSI) 49.24 42.36
Support Level $162.06 $68.49
Resistance Level $183.11 $70.74
Average True Range (ATR) 5.66 2.19
MACD -0.90 1.33
Stochastic Oscillator 34.81 68.86

Price Performance

Historical Comparison
ICLR
SNEX

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

About SNEX StoneX Group Inc.

StoneX Group Inc is a brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: